The Viremic Phase and Humoral Immune Response Against African Horse Sickness Virus That Emerged in Thailand in 2020.

Abstract

African horse sickness (AHS), a life-threatening disease caused by African horse sickness virus serotype 1 (AHSV-1), emerged in Thailand in February 2020 with 607 cases and a 93% fatality rate. The outbreak was mitigated by vector control and a live attenuated virus (LAV) vaccine. Information regarding viremia and immunity after infection and vaccination during outbreaks are essential for controlling disease transmission. This study evaluated these parameters in 15 infected naïve horses and 11 vaccinated horses during the 2020 outbreak. Whole blood was collected and subjected to RT real-time PCR to detect viremia up to 52 weeks post-infection. ASHV-specific antibodies were accessed by blocking ELISA until 37 weeks post-vaccination. In both groups, viremia appeared in the first week and lasted until week 5 in 25% of the horses. Moreover, seroconversion occurred at week 5 in 73.3% of infected horses and at week 3 in 90% of vaccinated horses. Antibodies persisted in both groups until the end of study, with more uniform levels in vaccinated animals. Chronological relations among clinical signs, viremia, and immunity were analyzed. These findings support the use of insect-proof housing for horses for at least 5 weeks after exposure or vaccination, and provide essential insights into AHSV epidemiology and control.